Home » Eli Lilly: FDA Still Reviewing Cymbalta for Chronic Pain
Eli Lilly: FDA Still Reviewing Cymbalta for Chronic Pain
Indianapolis-based Eli Lilly & Co. said U.S. regulators are still reviewing its application for an additional use of the antidepressant Cymbalta for chronic pain.
IndyStar
IndyStar
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May